Literature DB >> 14220404

INFECTIOUS DISEASES. ANNUAL REVIEW OF SIGNIFICANT PUBLICATIONS.

H A REIMANN.   

Abstract

Keywords:  ANTIBIOTICS; COMMUNICABLE DISEASES; INFECTION; REVIEW

Mesh:

Substances:

Year:  1964        PMID: 14220404      PMCID: PMC2482631          DOI: 10.1136/pgmj.40.468.570

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  169 in total

1.  TREATMENT OF TRICHINOSIS. CASE REPORT.

Authors:  G L SPAETH; R E ADAMS; A M SOFFE
Journal:  Arch Ophthalmol       Date:  1964-03

2.  VIRUSES ASSOCIATED WITH UPPER RESPIRATORY ILLNESSES IN ADULTS.

Authors:  W J MOGABGAB
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

3.  ALEUTIAN-MINK DISEASE IN MAN.

Authors:  I CHAPMAN; F A JIMENEZ
Journal:  N Engl J Med       Date:  1963-11-28       Impact factor: 91.245

4.  A THIRTEEN-YEAR FOLLOW-UP STUDY OF AN EPIDEMIC OF INOCULATION TUBERCULOSIS IN CHILDREN CAUSED BY VACCINATION AGAINST PERTUSSIS.

Authors:  S OKA; M SATO
Journal:  Am Rev Respir Dis       Date:  1963-10

5.  IDENTIFICATION OF COXSACKIE AND ECHO VIRUS ISOLATES WITH FLUORESCENT ANTIBODY.

Authors:  M H HATCH
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

6.  A LONG-DELAYED PRIMARY ATTACK OF OVALE MALARIA.

Authors:  W TRAGER; H MOST
Journal:  Am J Trop Med Hyg       Date:  1963-11       Impact factor: 2.345

7.  CAT SCRATCH DISEASE WITH ENCEPHALOPATHY.

Authors:  F BROOKSALER
Journal:  Am J Dis Child       Date:  1964-02

8.  ISOLATION OF RUBELLA VIRUS FROM CASES IN BRITAIN.

Authors:  K MCCARTHY; C H TAYLOR-ROBINSON; S E PILLINGER
Journal:  Lancet       Date:  1963-09-21       Impact factor: 79.321

9.  FATAL LIVER DISEASE AFTER INTRAVENOUS ADMINISTRATION OF TETRACYCLINE IN HIGH DOSAGE.

Authors:  J C SCHULTZ; J S ADAMSON; W W WORKMAN; T D NORMAN
Journal:  N Engl J Med       Date:  1963-11-07       Impact factor: 91.245

10.  Clinical patterns in severe tetanus.

Authors:  K KLOETZEL
Journal:  JAMA       Date:  1963-08-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.